Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Fibromyalgia (CANNFIB)
NCT04729179Phase 3Completed
- Start
- Mar 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in fibromyalgia (FM). Started Mar 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04729179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729179.